MedPath
HSA Approval

ALLUMAG M TABLET

SIN09499P

ALLUMAG M TABLET

ALLUMAG M TABLET

September 25, 1997

PHARMATECH MEDICAL ENTERPRISE PTE LTD

PHARMATECH MEDICAL ENTERPRISE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMATECH MEDICAL ENTERPRISE PTE LTD
Licence HolderPHARMATECH MEDICAL ENTERPRISE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A02AD01

ordinary salt combinations

Manufacturer Information

PHARMATECH MEDICAL ENTERPRISE PTE. LTD.

CHULIA PHARMA SDN BHD

Active Ingredients

ALUMINIUM HYDROXIDE (DRIED GEL)

120 mg

Aluminum hydroxide

MAGNESIUM TRISILICATE

250 mg

Magnesium trisilicate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ALLUMAG M TABLET - HSA Approval | MedPath